|
V.A. Golovacheva, V.A. Parfenov
MODERN TACTICS OF MANAGEMENT OF PATIENTS WITH DIABETIC POLYNEUROPATHY
|
№5 / 2016
|
|
V.N. Khramilin, V.L. Andreeva, I.Yu. Demidova
COMBINATION THERAPY OF PAINFUL DIABETIC POLYNEUROPATHY: RESULTS OF PILOT STUDY
|
№16 / 2014
|
|
Yu.E. Azimova (1,2)
DIABETIC POLYNEUROPATHY: APPROACHES TO THE THERAPY
|
№5 / 2014
|
|
O.L.Badalyan , A.A.Savenkov
PATHOGENETIC APPROACHES TO THE THERAPY OF DIABETIC POLYNEUROPATHY
|
№5 / 2014
|
|
I.V. Guryeva, O. V. Svetlova
Perspective Strategy In The Treatment Of Diabetic Polyneuropathy: The Role Of Antioxidant Therapy
|
№5 / 2013
|
|
Galstyan K.O.
Importance Of Antioxidant Therapy In The Treatment Of Diabetic Polyneuropathy
|
№16 / 2012
|
|
I.A. Strokov
Painful Diabetic Polyneuropathy
|
№7 / 2012
|
|
N.V. Matveev
Evaluation Of The Clinical And Economic Efficiency Of Pharmacotherapy Of Diabetic Polyneuropathy
|
№19 / 2011
|
|
Begma A.N., Begma I.V.
Pathogenetic Aspects Of Treatment Of Distal Peripheral Polyneuropathy In Patients With Diabetes Mellitus
|
№3 / 2011
|
|
A.Shilov, A.Avshalumov С. 5661
Milgamma And Milgamma Compositum In Treatment Of Diabetic Polyneuropathy
|
№20 / 2009
|
|
L.T. Grigoryan
Corrector Of Tissue Metabolism Solcoseril In The Treatment Of Diabetic Complications
|
№17 / 2009
|
|
A.N. Gracianskaja
Milgamma And Milgamma-compositum In The Treatment Of Polyneuropathies
|
№12 / 2009
|
Русский
